✦ LIBER ✦

Immunogenicity and safety of a measles–mumps–rubella–varicella vaccine following a 4-week or a 12-month interval between two doses

✍ Scribed by H.C. Rümke; H.P. Loch; K. Hoppenbrouwers; C. Vandermeulen; A. Malfroot; K. Helm; M. Douha; P. Willems

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of measles-mum

✍ Y. Gillet; G.C. Steri; U. Behre; J.P. Arsène; X. Lanse; K. Helm; S. Esposito; N. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 378 KB

Immunogenicity and safety of a two-dose

✍ Timo Vesikari; Thomas Becker; Vincent Gajdos; Anne Fiquet; Stéphane Thomas; Patr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 918 KB

Safety and immunogenicity of a measles–m

✍ Scott A. Halperin; Giuseppe Ferrera; David Scheifele; Gerald Predy; Giuseppe Ste 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Vaccine-induced measles virus antibodies

✍ Irja Davidkin; Martti Valle 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Comparison of immunogenicity and reactog

✍ J. Klinge; S. Lugauer; K. Korn; U. Heininger; K. Stehr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Immunogenicity and safety of concomitant

✍ Yves Gillet; Pirmin Habermehl; Stéphane Thomas; Cécile Eymin; Anne Fiquet 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 304 KB